Methemoglobinemia screening: Difference between revisions
Jump to navigation
Jump to search
Line 9: | Line 9: | ||
==Screening== | ==Screening== | ||
Currently we have a screening test for G6PD deficiency. It is called methemoglobin reduction test (MRT), it is not expensive and it uses cord blood of neonates to check for the enzyme deficiency. Even though it has low sensitivity around 65%, it does have acceptable specificity arounf 90%. | Currently we have a screening test for G6PD deficiency. It is called methemoglobin reduction test (MRT), it is not expensive and it uses cord blood of neonates to check for the enzyme deficiency. Even though it has low sensitivity around 65%, it does have acceptable specificity arounf 90%. | ||
<ref | <ref name="PMID: 11529386">{{cite journal |author=Sanpavat S1, Nuchprayoon I, Kittikalayawong A, Ungbumnet W. ''et al.'' |title=The value of methemoglobin reduction test as a screening test for neonatal glucose 6-phosphate dehydrogenase deficiency. |J Med Assoc Thai. 2001 Jun;84 Suppl 1:S91-8. |url=}}</ref> | ||
[[Category:Hematology]] | [[Category:Hematology]] |
Revision as of 09:48, 29 April 2018
Methemoglobinemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Methemoglobinemia screening On the Web |
American Roentgen Ray Society Images of Methemoglobinemia screening |
Risk calculators and risk factors for Methemoglobinemia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Screening
Currently we have a screening test for G6PD deficiency. It is called methemoglobin reduction test (MRT), it is not expensive and it uses cord blood of neonates to check for the enzyme deficiency. Even though it has low sensitivity around 65%, it does have acceptable specificity arounf 90%.